Skip to main content
Cannabix Technologies Inc logo

Cannabix Technologies Inc — Investor Relations & Filings

Ticker · BLO ISIN · CA13765L1013 LEI · 529900ELT8R2ZTQS9H10 CSE Manufacturing
Open in API
Filings indexed 411 across all filing types
Latest filing 2026-05-05 Regulatory Filings
Country CA Canada
Listing CSE BLO

About Cannabix Technologies Inc

https://cannabixtechnologies.com/

Cannabix Technologies Inc. develops innovative, non-invasive breath testing and screening technologies for detecting and quantifying substance impairment. The company specializes in creating reliable tools for measuring THC (tetrahydrocannabinol) in breath, serving law enforcement and workplace safety needs by providing an alternative to outdated marijuana testing methods. Cannabix also offers fully automated, contactless breath alcohol screening systems. These cutting-edge solutions enhance safety and compliance by delivering efficient and accessible tools for drug and alcohol testing.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings
2026-05-05 English
News release - English.pdf
Regulatory Filings Classification · 75% confidence The document is a corporate press release announcing conference presentations and product panels by Omega Laboratories at the 2026 NDASA Conference, including forward‐looking statement disclaimers. It does not contain financial results, director changes, M&A details, dividends, or a report itself. It is a general company announcement, best fitting the fallback category for miscellaneous regulatory/press announcements (RNS).
2026-04-21 English
News release - English.pdf
Regulatory Filings Classification · 90% confidence The document is a regulatory form (Form 45-106F1 Report of Exempt Distribution) filed under Canadian securities rules (NI 45-106) detailing the distribution of securities, purchasers, exemptions relied upon, compensation, etc. It is neither an annual/interim report nor an earnings release, nor a management/board change notice. It is a mandatory regulatory filing that does not fit into other specific categories, so it should be classified as a general Regulatory Filing (RNS).
2026-04-21 English
News release - English.pdf
Regulatory Filings Classification · 85% confidence The document is a corporate press release announcing the delivery of a product (Marijuana Breath Test) to a customer, with marketing and commercial context, forward-looking statements, but contains no financial results, no AGM materials, no management changes, no securities transactions, no dividend or share issuance, no regulatory or legal proceedings, nor presentation decks or investor materials. It does not fit any specialized category and is a general corporate announcement, so it falls under the fallback category “Regulatory Filings” (RNS).
2026-04-02 English
News release - English.pdf
Regulatory Filings Classification · 12% confidence The document is a corporate press release announcing the commercial delivery of a new product (Marijuana Breath Test) to an industrial client. It does not present financial results, a shareholder vote, management changes, or regulatory filings such as an annual report, proxy, or M&A notice. It is a general announcement that does not fit into any of the more specific categories, making “Regulatory Filings (RNS)” the appropriate fallback category.
2026-04-02 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings
2026-03-27 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.